首页> 外文会议>Annual meeting exposition of the Controlled Release Society >SMA SMA-copolymer conjugates of AHPP: a polymeric inhibitor of xanthine oxidase with therapeutic potentials against hypertension
【24h】

SMA SMA-copolymer conjugates of AHPP: a polymeric inhibitor of xanthine oxidase with therapeutic potentials against hypertension

机译:AHPP的SMA SMA-共聚物缀合物:具有治疗潜力的黄嘌呤氧化酶的聚合物抑制剂免受高血压

获取原文

摘要

4-amino-6-hydroxypyrazolo[3,4-d]pyrimidine (AHPP) is a potent inhibitor of xanthine oxidase (XO) and showed remarkable antihypertensive effect. However, its poor water-solubility hampers its therapeutic application. In this study we prepared a water soluble polymeric conjugates of AHPP, by using a styrene maleic acid copolymer (SMA, SMA-AHPP), which showed similar inhibitory activity against XO comparable to parental AHPP. Upon intravenously injection or oral administration of SMA-AHPP blood pressures of SHR rats significantly reduced, which continued for at least 24 h. These findings strongly suggest the potential value of SMA-AHPP as an antihypertensive agent.
机译:4-氨基-6-羟基吡唑唑[3,4-D]嘧啶(AHPP)是黄嘌呤氧化酶(XO)的有效抑制剂,并显示出显着的抗高血压作用。然而,其水溶性差的水溶性妨碍了其治疗应用。在该研究中,我们制备了通过使用苯乙烯马来酸共聚物(SMA,SMA-AHPP)的水溶性聚合物缀合物,其显示出与父母AHPP相当的XO类似的抑制活性。在静脉内注射或口服SMA-AHPP血压的SHR大鼠显着降低,这持续至少24小时。这些发现强烈建议SMA-AHPP作为抗高血压剂的潜在价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号